These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 813612)

  • 41. [Pseudomonas aeruginosa hospital infection in a pediatric unit. Typing by pyocine production].
    Fernandez H; Lembke C
    Rev Chil Pediatr; 1975; 46(1):81-4. PubMed ID: 809813
    [No Abstract]   [Full Text] [Related]  

  • 42. Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189.
    Naz SA; Jabeen N; Sohail M; Rasool SA
    Braz J Microbiol; 2015; 46(4):1147-54. PubMed ID: 26691474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of F-type pyocins of Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1981 Jun; 89(6):1721-36. PubMed ID: 6793563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.
    Farkas-Himsley H; Cheung R
    Cancer Res; 1976 Oct; 36(10):3561-7. PubMed ID: 953984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Second possibility of employing typization of Pseudomonas aeruginosa by means of pyocins (pyocinotypia) (author's transl)].
    Zahradnický J
    Cesk Epidemiol Mikrobiol Imunol; 1979 Nov; 28(6):321-5. PubMed ID: 161865
    [No Abstract]   [Full Text] [Related]  

  • 46. Bacteriocins, effect on mammalian cells: mode of action analyzed by flow cytometry and cell sorting.
    Farkas-Himsley H; Musclow CE
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(6):597-603. PubMed ID: 6783310
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pyocin typization of Pseudomonas aeruginosa].
    Vlajinac H
    Srp Arh Celok Lek; 1974 Dec; 102(12):901-11. PubMed ID: 4219453
    [No Abstract]   [Full Text] [Related]  

  • 48. [Bacteriocinogeny in Pseudomonas aeruginosa].
    Maresz-Babczyszyn J; Sokalska M
    Med Dosw Mikrobiol; 1977; 29(3):179-89. PubMed ID: 412020
    [No Abstract]   [Full Text] [Related]  

  • 49. Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents.
    Blasco L; de Aledo MG; Ortiz-Cartagena C; Blériot I; Pacios O; López M; Fernández-García L; Barrio-Pujante A; Hernández-Garcia M; Cantón R; Tomás M
    Sci Rep; 2023 Jan; 13(1):117. PubMed ID: 36596850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Quantitative and qualitative measurement of the activity of pyocins of Ps. aeruginosa (author's transl)].
    García Quintana H; Asenjo S; Hernández A; Polette M
    Rev Med Chil; 1979 Jun; 107(6):471-8. PubMed ID: 120964
    [No Abstract]   [Full Text] [Related]  

  • 51. Typing of non-serogroupable Neisseria meningitidis by means of sensitivity to R-type pyocines of Pseudomonas aeruginosa.
    Blackwell CC; Law JA
    J Infect; 1981 Dec; 3(4):370-8. PubMed ID: 6821098
    [No Abstract]   [Full Text] [Related]  

  • 52. [Three-dimensional organization of the capsid of pyocin R I].
    Edintsov IM; Ivanitskiĭ GR; Kuniskiĭ AS; Poglazov BF; Turkin AI
    Dokl Akad Nauk SSSR; 1979; 247(5):1272-4. PubMed ID: 114380
    [No Abstract]   [Full Text] [Related]  

  • 53. Phagovar determination of Pseudomonas aeruginosa and a comparison of the results with mitomycin C induced pyocin production.
    Sticht-Groh V
    Zentralbl Bakteriol A; 1981; 249(2):225-34. PubMed ID: 6791406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pyocin typing of Pseudomonas aeruginosa from the urinary tract].
    Yumul C
    Mikrobiyol Bul; 1983 Jul; 17(3):198-203. PubMed ID: 6423940
    [No Abstract]   [Full Text] [Related]  

  • 55. Purification and characteristics of pyocin B39 II. Physical and chemical properties.
    Chen C; Tai F
    Antimicrob Agents Chemother; 1972 Feb; 1(2):159-63. PubMed ID: 4218942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron availability shapes the evolution of bacteriocin resistance in Pseudomonas aeruginosa.
    Inglis RF; Scanlan P; Buckling A
    ISME J; 2016 Aug; 10(8):2060-6. PubMed ID: 26905630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyocin types of clinical strains of Pseudomonas aeruginosa isolated in Morelia, México (1980-1984).
    Cervantes Vega C; Chávez J; Padilla ME; Rivera AN; Vaca S
    Rev Latinoam Microbiol; 1986; 28(4):287-91. PubMed ID: 3108986
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pseudomonas aeruginosa strains: synergism and pyocinogenia induction].
    García-Quintana HG; Martińez MA
    Rev Med Chil; 1988 Nov; 116(11):1167-71. PubMed ID: 3151707
    [No Abstract]   [Full Text] [Related]  

  • 59. Pyocin sensitivity of Pseudomonas species.
    Jones LF; Thomas ET; Stinnett JD; Gilardi GL; Farmer JJ
    Appl Microbiol; 1974 Jan; 27(1):288-9. PubMed ID: 4203785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A simple photometric method for determination of the activity of pyrocin R1.
    Kumazaki T; Ishii S
    J Biochem; 1982 Mar; 91(3):817-23. PubMed ID: 6804454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.